The identification of a conserved binding motif within human papillomavirus type 16 E6 binding peptides, E6AP and E6BP.
about
Association of E6AP (UBE3A) with human papillomavirus type 11 E6 protein.The E1E4 protein of human papillomavirus type 16 associates with a putative RNA helicase through sequences in its C terminusHuman papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activityHuman papillomavirus 16 E6 oncoprotein interferences with insulin signaling pathway by binding to tuberinE3-ubiquitin ligase/E6-AP links multicopy maintenance protein 7 to the ubiquitination pathway by a novel motif, the L2G boxPapillomavirus E6 oncoproteins.Cutaneous papillomavirus E6 oncoproteins associate with MAML1 to repress transactivation and NOTCH signalingPeptide interactions stabilize and restructure human papillomavirus type 16 E6 to interact with p53Strategies for bacterial expression of protein-peptide complexes: application to solubilization of papillomavirus E6Transformation by bovine papillomavirus type 1 E6 requires paxillin.A novel peptide motif binding to and blocking the intracellular activity of the human papillomavirus E6 oncoprotein.The human papillomavirus 16 E6 protein binds to Fas-associated death domain and protects cells from Fas-triggered apoptosis.The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha.The full-length isoform of human papillomavirus 16 E6 and its splice variant E6* bind to different sites on the procaspase 8 death effector domain.Multiple functions of human papillomavirus type 16 E6 contribute to the immortalization of mammary epithelial cellsCooperative transformation and coexpression of bovine papillomavirus type 1 E5 and E7 proteinsA mutant of human papillomavirus type 16 E6 deficient in binding alpha-helix partners displays reduced oncogenic potential in vivo.The human papillomavirus E6 protein and its contribution to malignant progression.Human papillomavirus E6 and E7 oncoproteins as risk factors for tumorigenesis.The PDZ ligand domain of the human papillomavirus type 16 E6 protein is required for E6's induction of epithelial hyperplasia in vivo.Induction of apoptosis in human papillomaviruspositive cancer cells by peptide aptamers targeting the viral E6 oncoprotein.Mechanisms of human papillomavirus-induced oncogenesis.Cellular binding partners of the human papillomavirus E6 protein.The interaction between human papillomavirus type 16 and FADD is mediated by a novel E6 binding domain.Papillomavirus E6 proteins.HPV E6 protein interacts physically and functionally with the cellular telomerase complex.Identification of inhibitors to papillomavirus type 16 E6 protein based on three-dimensional structures of interacting proteins.The active form of E6-associated protein (E6AP)/UBE3A ubiquitin ligase is an oligomer.HPV E6 oncoprotein as a potential therapeutic target in HPV related cancers.Activation of cap-dependent translation by mucosal human papillomavirus E6 proteins is dependent on the integrity of the LXXLL binding motif.The human papillomavirus type 16 E6 oncoprotein activates mTORC1 signaling and increases protein synthesis.The E6AP ubiquitin ligase is required for transactivation of the hTERT promoter by the human papillomavirus E6 oncoprotein.The human papillomavirus 16 E6 protein binds to tumor necrosis factor (TNF) R1 and protects cells from TNF-induced apoptosis.Human papillomavirus type 16 E6 and E7 oncoproteins act synergistically to cause head and neck cancer in mice.
P2860
Q24305966-24A1D3D0-33BA-4C66-A2C6-91835282F302Q24515067-1971249A-38D4-40EF-B476-D517328D83DBQ24599944-CD00B88F-F341-47FE-9BF6-207145555CC4Q28264728-1AFE13DE-6FCB-442E-8581-A30297B0FA7CQ28291338-E796350F-874C-4BD5-B6C0-D94FCC74A249Q30410553-5BAF9A29-8DC6-487E-A258-F2BECF995041Q30419809-B7BB93A1-48AC-4ABA-9A99-4E12C6F7FFCBQ30421662-04977C6B-4ED5-49D5-8880-F5FA4970C3FAQ30424376-12FED1D7-0963-4623-9EC8-963EC4387E7FQ30441087-B902D6EB-0377-4F3C-8B3B-23A415CE9344Q30855284-A2942088-8EAA-4262-B3F7-829F4589DB0BQ33292139-9558065C-F641-4529-A13F-B53293A7D863Q33292312-392A3CB5-30B2-4268-B9C0-7A4E626B18D1Q33614450-67BC3576-342C-493A-A6BC-C52E2790DD63Q33649218-0B20F17B-0B26-4317-9B05-1A8BA8B9F7C3Q33835105-78ADBC28-4A52-41CF-B4FA-6BA5017C2F33Q34352200-2AA3443B-8763-4B70-9FA5-5EA10C007074Q34468780-517C7F45-DA88-437A-8078-504A4E293A73Q34980270-31714D02-4578-4AFD-9A45-FFE73FEB9592Q35020321-89FD435C-BF62-4500-8B0F-E84D374A3D3CQ35797390-611FC2BC-85B0-4B1B-9FDD-D9E124E23625Q35915935-3A004A16-DA96-4CB5-A3EF-44A1774D3070Q36473674-6059ABF5-09CB-4714-8516-1B312A772AC0Q36898915-D708D73C-DCF0-4970-A24C-DBE7083C504DQ37350446-28D502FB-5F53-47DA-863C-A9A6C5EF3D9FQ37413480-1AACD80B-B7B8-41C4-B461-26D78F3E1F8AQ37419555-E0BC980B-5E5F-48B4-83B0-98E9F428E832Q37459194-726F576E-4066-42C2-B8D4-F20F1431D3D8Q38149333-C8E8CBF2-49DB-4E86-99FA-76DF355F0E1BQ39354536-6DC0825B-38AA-414B-9E26-3AB7250FB1A1Q39680127-87720D6B-C4D4-478F-B8B4-9609A40BB3C7Q40470084-5B06E928-E300-4ABE-885B-D6E4E1F29F62Q40740004-23396A5F-F8DA-4262-AFCD-7AF5AB211899Q42670506-8FB1E4E8-89CB-4B0C-91AC-5927FF785248
P2860
The identification of a conserved binding motif within human papillomavirus type 16 E6 binding peptides, E6AP and E6BP.
description
1998 nî lūn-bûn
@nan
1998 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
The identification of a conser ...... nding peptides, E6AP and E6BP.
@ast
The identification of a conser ...... nding peptides, E6AP and E6BP.
@en
type
label
The identification of a conser ...... nding peptides, E6AP and E6BP.
@ast
The identification of a conser ...... nding peptides, E6AP and E6BP.
@en
prefLabel
The identification of a conser ...... nding peptides, E6AP and E6BP.
@ast
The identification of a conser ...... nding peptides, E6AP and E6BP.
@en
P2093
P1476
The identification of a conser ...... nding peptides, E6AP and E6BP.
@en
P2093
P304
P356
10.1099/0022-1317-79-2-371
P407
P478
79 ( Pt 2)
P577
1998-02-01T00:00:00Z